• Rogers Corporation recently appointed Ali El-Haj as its President, Chief Executive Officer and a member of the Board, formalizing his role after serving as interim CEO and aligning his compensation with a US$750,000 base salary, a target annual incentive equal to base pay, and a US$5,000,000 long-term equity grant.
• The Board’s decision ties a substantial portion of El-Haj’s pay to multi-year restricted stock units, signaling a focus on longer-term performance and closer alignment between executive incentives and shareholder outcomes.
• We’ll now examine how El-Haj’s permanent appointment and equity-based incentives could reshape Rogers’ investment narrative and future priorities.

Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

Rogers Investment Narrative Recap

To own Rogers today, you have to believe the company can turn its materials portfolio into steadier growth while fixing past EV and curamik setbacks. The biggest near term catalyst remains execution on restructuring and margin recovery, while a key risk is that weaker EV demand and intense Asian competition keep power substrate volumes and pricing under pressure. El-Haj’s permanent appointment and equity-heavy package signal continuity in leadership, but do not, by themselves, materially change these near term drivers.

Among recent announcements, the most relevant alongside the CEO news is Rogers’ Q1 2026 return to profitability, with US$200.5 million in sales and US$4.5 million in net income. That step back into the black matters for a business coming off restructuring, because it gives El-Haj a financial base to push on earnings recovery at the same time as Rogers is still exposed to end market uncertainty and restructuring execution risk.

Yet investors should be aware that if EV demand stays weak and customer concentration worsens, the pressure on curamik and overall margins could...

Rogers' narrative projects $973.0 million revenue and $122.3 million earnings by 2029. This requires 6.3% yearly revenue growth and an earnings increase of about $184 million from -$61.8 million today.

Uncover how Rogers' forecasts yield a $124.33 fair value, a 8% downside to its current price.

Exploring Other Perspectives

Before this CEO move, the most bullish analysts were already assuming revenue could reach about US$1.0 billion and earnings about US$318.0 million by 2029, which is far more optimistic than consensus and rests heavily on a smooth ramp at the new curamik facility in China; El-Haj’s appointment may reinforce or challenge that view, so it is worth weighing how your own expectations compare to such aggressive forecasts.

Explore 2 other fair value estimates on Rogers - why the stock might be worth as much as $124.33!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Rogers research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free Rogers research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rogers' overall financial health at a glance.

Interested In Other Possibilities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.
• The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.